Pharmalys kicks off 2024 under the banner of excellence!

Jan 1, 2024 | Newsletters

As we welcome in the new year, Pharmalys celebrates our employees

At Pharmalys, we never lose sight of the fact that our people are the greatest asset of our company. We are highly committed to their professional and personal development and we strive to create a stimulating and rewarding working environment for everyone.

At the end of each year, Pharmalys organises the Recognition Awards. Each member of the team places a vote for 3 colleagues based on attributes worthy of celebrating, such as a positive mindset, proficiencies, and/or nice behaviour.


We wish to congratulate Edem (Senior CRA), Assane (CRA Manager) and Bator (Office Manager), who received the most nominations for the 2023 Pharmalys Recognition Awards!

We also wish to extend our gratitude to the whole Pharmalys team for your continued hard work and positivity that you bring to the workplace. Learn more Our People | Pharmalys

 

 

Excellence is our creed

At Pharmalys, we foster a culture of excellence. Excellence defines our mission to help advance health through data excellence; it drives our daily work, it characterises our relationships with customers Accueil | Pharmalys. In alignment with our culture and values Our Values | Pharmalys, we created Continuous Excellence, a soft skills training programme for everyone at Pharmalys, because excellence in the workplace cannot be achieved without developing our soft skills.

Harnessing soft skills is almost as important as hard skills

We live in a world where job roles are rapidly everchanging. To meet the demands of our positions, we require not only role-specific knowledge and skills, but the capacity to leverage hard skills in alignment with our organisational roles. Read more:  Continuous Excellence – Soft Skills Training Programme

 

Supporting and expanding the Clinical Research ecosystem in Africa is part of Pharmalys’ mission

With continued interest in advancing clinical trial conduct in sub-Saharan Africa, there is a growing imperative to strengthen pharmacovigilance systems, develop and reinforce the capacity of Ethics Committees, Regulatory bodies, and clinical research personnel in the region. With the increasing complexity of research designs, the demand for deeper technical expertise of REC members to review complex and emerging study designs rises, the review schedules must be achieved despite unusual study designs, and effective pharmacovigilance systems are requested to protect populations, and highlight possible safety issues with new interventions.

Lack of expertise has been cited as one of the barriers hindering conduct of clinical trials in developing countries. It has proven difficult to develop a strong track clinical research record to compete successfully for international funding, due to a lack of physical infrastructure, inadequately trained personnel, and weak institutions in countries with high disease burdens.

It has become clear that strengthening research capacity in Africa is critical to enhancing Africa’s self-sufficiency and preparedness for the next public health emergency, as well as the ability to fight against the endemic infectious diseases. Read more: Supporting and expanding the Clinical Research ecosystem in Africa is part of Pharmalys’ mission

Pharmalys is experienced in delivering capacity building workshops Capacity Building | Pharmalys

Capacity building programme AMELIORER, in Benin

The Pharmalys team has conceived and delivered seven capacity building programmes to Ethics Committees and Regulatory Authorities throughout Africa so far. These include ERUDIT in Togo, ERECIS in eSwatini, BRECOR in Rwanda, STREC in Ghana, AMELIORER in Benin, CECaBI in Côte d’Ivoire, and ERC in The Gambia.

One of Pharmalys’ most recent programmes was Ethics and Regulatory Capacity (ERC) in The Gambia. Health research is a crucial pillar in the development of the health sector in this country. Aligned with the Commission on Health Research for Development (COHRED), which states that ‘building research capacity in developing countries is one of the most powerful, cost-effective and sustainable ways of advancing health and development’, a consortium of different partners, named Ethics and Regulatory Capacity in The Gambia (ERC The Gambia), collaborates to transform the ethical and regulatory practices in the country. Read more: Supporting and expanding the Clinical Research ecosystem in Africa is part of Pharmalys’ mission

Newsletter July 2024

Newsletter July 2024

Pharmalys Ltd: Our Commitment to Quality As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality...

Our Soft Skills Training Programme was a huge success!

Our Soft Skills Training Programme was a huge success!

Since 2008, Pharmalys Ltd has seen consistent growth, with a notable acceleration over the past two years, expanding from 30 to 50 employees. The Pharmalys team is primarily composed of remote workers spread across the globe, from USA to India, the UK to South Africa....

Barriers to cancer clinical trials participation

Barriers to cancer clinical trials participation

Ongoing cancer clinical trials in Africa in 2020 From Unger J.M. et al. JNCI J Natl Cancer Inst 2019. * Circles represent individual clinical trials * Colors of the circles represent the study’s primary sponsor type   The cancer clinical trials context Clinical...

Pharmalys Ltd: Our Commitment to Quality

Pharmalys Ltd: Our Commitment to Quality

As an international Contract Research Organisation (CRO), Pharmalys Ltd has always been dedicated to delivering excellence in every service we provide, ensuring quality at every step. Our Business Excellence and Quality Management team is integral to all our services,...

Future prospects in clinical research

Future prospects in clinical research

Strategies for the future of clinical research: decentralised clinical trials Challenges with traditional clinical trials The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system...

Five reasons why we should invest in women-owned businesses

Five reasons why we should invest in women-owned businesses

In the pursuit of inclusive economic growth, one of the most important avenues to explore is the support of women-owned businesses. Across the globe, women entrepreneurs are not just contributors to economies, they are agents of change, driving innovation, creating...

Newsletter March 2024

Newsletter March 2024

  #CountAfricaIn in the field of clinical research Pharmalys team takes the floor! ­ Pharmalys team members give their feedback on how to improve the Pharmalys Voice concept Introduced in March 2023, Pharmalys Voice represents a recurrent team gathering designed...